Mangalam Drugs & Organics Ltd. Statistics
Want to see IN:MANGALAM full AI Analyst Report?
Mangalam Drugs & Organics Ltd. (MANGALAM) Stock Statistics & Valuation Metrics
Total Valuation
Mangalam Drugs & Organics Ltd. has a market cap or net worth of INR 468.99M. The enterprise value is INR 1.38B.
- Market Cap
- INR 468.99M
- Enterprise Value
- INR 1.38B
Share Statistics
Mangalam Drugs & Organics Ltd. has 15,828,248 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 15,828,248
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Mangalam Drugs & Organics Ltd.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -14.06%.
- Return on Equity (ROE)
- -0.43
- Return on Assets (ROA)
- -0.14
- Return on Invested Capital (ROIC)
- -14.06%
- Return on Capital Employed (ROCE)
- -0.28
- Revenue Per Employee
- 7.28M
- Profits Per Employee
- -1.39M
- Employee Count
- 319
- Asset Turnover
- 0.74
- Inventory Turnover
- 2.03
Valuation Ratios
The current PE Ratio of Mangalam Drugs & Organics Ltd. is -1.18. Mangalam Drugs & Organics Ltd.’s PEG ratio is 0.02.
- PE Ratio
- -1.18
- PS Ratio
- 0.17
- PB Ratio
- 0.51
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.02
Income Statement
In the last 12 months, Mangalam Drugs & Organics Ltd. had revenue of 2.32B and earned -444.00M in profits. Earnings per share was -28.05.
- Revenue
- 2.32B
- Gross Profit
- 232.46M
- Operating Income
- -331.26M
- Pretax Income
- -485.71M
- Net Income
- -444.00M
- EBITDA
- -149.03M
- Earnings Per Share (EPS)
- -28.05
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Mangalam Drugs & Organics Ltd. pays an annual dividend of INR 0.50, resulting in a dividend yield of ―
- Dividend Per Share
- INR 0.50
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -84.79%
Stock Price Statistics
- Beta
- 0.57
- 52-Week Price Change
- -53.11%
- 50-Day Moving Average
- 30.91
- 200-Day Moving Average
- 29.78
- Relative Strength Index (RSI)
- 49.40
- Average Volume (3m)
- 7,990
Important Dates
Mangalam Drugs & Organics Ltd. upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 14, 2027
- Ex-Dividend Date
- Dec 21, 2017
Financial Position
Mangalam Drugs & Organics Ltd. as a current ratio of 0.79, with Debt / Equity ratio of 102.35%
- Current Ratio
- 0.79
- Quick Ratio
- 0.27
- Debt to Market Cap
- 2.37
- Net Debt to EBITDA
- -7.03
- Interest Coverage Ratio
- -2.04
Taxes
In the past 12 months, Mangalam Drugs & Organics Ltd. has paid -41.71M in taxes.
- Income Tax
- -41.71M
- Effective Tax Rate
- 0.09
Enterprise Valuation
Mangalam Drugs & Organics Ltd. EV to EBITDA ratio is -18.94, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.51
- EV to EBITDA
- -18.94
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Mangalam Drugs & Organics Ltd. has INR 8.35M in cash and marketable securities with INR 903.89M in debt, giving a net cash position of -INR 895.54M billion.
- Cash & Marketable Securities
- INR 8.35M
- Total Debt
- INR 903.89M
- Net Cash
- -INR 895.54M
- Net Cash Per Share
- -INR 56.58
- Tangible Book Value Per Share
- INR 35.21
Margins
Gross margin is 6.41%, with operating margin of -9.39%, and net profit margin of -14.53%.
- Gross Margin
- 6.41%
- Operating Margin
- -9.39%
- Pretax Margin
- -14.81%
- Net Profit Margin
- -14.53%
- EBITDA Margin
- -2.71%
- EBIT Margin
- -9.31%
Analyst Forecast
The average price target for Mangalam Drugs & Organics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -2.37%
- EPS Growth Forecast
- -92.45%
Scores
- Smart Score
- ―
- AI Score
- 50

